Neoadjuvant QL1706 Therapy for ESCC

Clinical trial NCT06908382 · RECRUITING

Trial details

NCT number: NCT06908382
Sponsor: Shandong Provincial Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Start date: 2025-04-28
Primary completion: 2026-12-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.